Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

References

Page 1

	Year	Citations
Antibody neutralization and escape by HIV-1 Xiping Wei, Julie M. Decker, Shuyi Wang, Nature Human RetrovirusImmunologyAntiviral ResponseAntibody NeutralizationAntibody Engineering	2003	2.4K
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies John R. Mascola, Gabriela Stiegler, Thomas C. VanCott, Nature Medicine VaccinationHuman RetrovirusImmunologyVaginal TransmissionAntiviral Therapy	2000	1.2K
Rapid evolution of the neutralizing antibody response to HIV type 1 infection Douglas D. Richman, Terri Wrin, Susan J. Little, Proceedings of the National Academy of Sciences Viral PersistenceHuman RetrovirusEnvelope GeneImmunologyPrimary Hiv Infection	2003	1.2K
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 Alexandra Trkola, Martin Purtscher, Thomas Muster, Journal of Virology ImmunologyMolecular BiologyAntigen ProcessingViral Structural ProteinAntibody 2G12	1996	1.1K
Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection Yunzhen Cao, Limo Qin, Linqi Zhang, New England Journal of Medicine	1995	1K
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 Thomas Muster, Franz Steindl, Martin Purtscher, Journal of Virology Conserved Neutralizing EpitopeHiv-1 Isolates MnImmunologyAntigen ProcessingViral Structural Protein	1993	985
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection Timothy W. Baba, Vladimír Liška, Regina Hofmann‐Lehmann, Nature Medicine Human RetrovirusImmunodeficienciesImmunologyAntiviral ResponseIgg1 Subtype Protect	2000	855
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies John R. Mascola, Mark G. Lewis, Gabriela Stiegler, Journal of Virology	1999	780
Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Michael B. Zwick, Aran F. Labrijn, Meng Wang, Journal of Virology	2001	780
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies James Μ. Binley, Terri Wrin, Bette Korber, Journal of Virology	2004	693

Page 1